Seres Therapeutics Inc (MCRB)

Apr 02, 2026

MCRB SEC FilingsSeres Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 02, 2026

Mar 31, 2026

Market Fear: Can Seres Therapeutics Inc weather a recessionDip Buying & Free High Return Stock Watch Alerts - baoquankhu1.vn

Mar 31, 2026

Mar 30, 2026

MCRB stock declines as Seres Therapeutics pauses SER-155 phase 2 study and shrinks headcount by 30% - MSN

Mar 30, 2026

Mar 29, 2026

Market Rankings: Is Seres Therapeutics Inc in a bullish channelTrade Volume Summary & Safe Capital Growth Stock Tips - baoquankhu1.vn

Mar 29, 2026

Mar 26, 2026

Layoff Tracker: Takeda Restructuring Will Affect Workforce, Could Include Layoffs - BioSpace

Mar 26, 2026

Mar 25, 2026

Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Below 50 Day Moving AverageHere's Why - MarketBeat

Mar 25, 2026

Mar 24, 2026

Seres Therapeutics cuts 25% of workforce to extend cash runway into Q2 2026 - MSN

Mar 24, 2026

Mar 23, 2026

Seres Therapeutics (MCRB) price target increased by 31.25% to 21.42 - msn.com

Mar 23, 2026

Mar 22, 2026

If You Invested $1,000 in Seres Therapeutics Inc (MCRB) - Stock Titan

Mar 22, 2026

Mar 17, 2026

Seres Therapeutics Sets 2026 Annual Shareholder Meeting Date - The Globe and Mail

Mar 17, 2026

Mar 17, 2026

MCRB (NASDAQ: MCRB) files Form 144 to resell 8,553 restricted shares - Stock Titan

Mar 17, 2026

Mar 17, 2026

Kelly Brady Net Worth (2026) - GuruFocus

Mar 17, 2026

Mar 16, 2026

Seres Therapeutics schedules 2026 annual meeting for June 9 By Investing.com - Investing.com India

Mar 16, 2026

Mar 16, 2026

Seres Therapeutics schedules 2026 annual meeting for June 9 - Investing.com

Mar 16, 2026

Mar 16, 2026

Seres Therapeutics sets 2026 annual meeting for June 9; shareholder proposal deadline Mar 26 - TradingView

Mar 16, 2026

Mar 16, 2026

Seres Therapeutics (MCRB) schedules 2026 meeting, sets proposal deadline - Stock Titan

Mar 16, 2026

Mar 16, 2026

Seres Therapeutics, Inc. (NASDAQ:MCRB) Short Interest Down 15.4% in February - MarketBeat

Mar 16, 2026

Mar 13, 2026

MCRB: Canaccord Genuity Maintains Buy Rating with $22 Target | M - GuruFocus

Mar 13, 2026

Mar 13, 2026

Seres Therapeutics (NASDAQ:MCRB) Receives Buy Rating from Canaccord Genuity Group - MarketBeat

Mar 13, 2026

Mar 12, 2026

Exit Recap: Is Seres Therapeutics Inc impacted by rising rates2026 Macro Impact & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn

Mar 12, 2026

Mar 12, 2026

Seres Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 12, 2026

Mar 12, 2026

Seres Therapeutics (NASDAQ:MCRB) Releases Earnings Results, Beats Expectations By $0.50 EPS - MarketBeat

Mar 12, 2026

Mar 12, 2026

Seres Therapeutics 2025 10-K: $0.8M Revenue, net income $5.70M - TradingView

Mar 12, 2026

Mar 12, 2026

Seres Therapeutics: Q4 Earnings Snapshot - marketscreener.com

Mar 12, 2026

Mar 12, 2026

Seres Therapeutics Reports 2025 Results, Highlights Refocused Pipeline - TipRanks

Mar 12, 2026

Mar 12, 2026

Seres (MCRB) Focuses on Advancing Biotherapeutics Portfolio - GuruFocus

Mar 12, 2026

Mar 12, 2026

Seres Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 12, 2026

Mar 12, 2026

Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - Bitget

Mar 12, 2026

Mar 12, 2026

Seres Therapeutics: Fourth Quarter Earnings Overview - Bitget

Mar 12, 2026

Mar 12, 2026

Seres Therapeutics (NASDAQ: MCRB) details 2025 profit, cash runway and SER-155 progress - Stock Titan

Mar 12, 2026

Mar 11, 2026

Seres Therapeutics (MCRB) awards 56,250 stock options to officer - Stock Titan

Mar 11, 2026

Mar 11, 2026

Seres Therapeutics (MCRB) officer Brady Kelly reports stock holdings - Stock Titan

Mar 11, 2026

Mar 11, 2026

Seres Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt - MarketScreener

Mar 11, 2026

Mar 09, 2026

Seres Therapeutics Inc expected to post a loss of $2.11 a shareEarnings Preview - TradingView

Mar 09, 2026

Mar 07, 2026

Is Seres Therapeutics Incs ROE strong enough2025 Trading Recap & Free Weekly Watchlist of Top Performers - baoquankhu1.vn

Mar 07, 2026

Mar 07, 2026

Rally Mode: Should I invest in Seres Therapeutics Inc before earningsGold Moves & High Accuracy Trade Signal Alerts - baoquankhu1.vn

Mar 07, 2026

Mar 06, 2026

Activity Recap: Should I invest in Seres Therapeutics Inc before earningsWeekly Stock Report & AI Forecasted Stock Moves - baoquankhu1.vn

Mar 06, 2026

Mar 06, 2026

Aug Action: Does Seres Therapeutics Inc have declining or rising EPSMarket Sentiment Report & Daily Entry Point Alerts - baoquankhu1.vn

Mar 06, 2026

Mar 06, 2026

Seres Therapeutics (MCRB) director Richard Kender awarded 150,000 stock options - Stock Titan

Mar 06, 2026

Mar 06, 2026

Seres Therapeutics (MCRB) grants 75,000-share stock option to officer Henn - Stock Titan

Mar 06, 2026

Mar 05, 2026

The Escalator: Seres Therapeutics, Bavarian Nordic, Moderna and more - Medical Marketing and Media

Mar 05, 2026

Mar 05, 2026

Seres Therapeutics (MCRB) Projected to Post Earnings on Thursday - MarketBeat

Mar 05, 2026

Mar 04, 2026

Human Microbiome Therapeutics Market to Reach US$ 5.86 Billion - openPR.com

Mar 04, 2026

Mar 04, 2026

MCRB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026